There are 2789 resources available
1338P - A phase III study comparing BCD-021, a bevacizumab biosimilar, and reference bevacizumab in patients with stage IIIB or IV non-squamous NSCLC
Presenter: Natalia Fadeeva
Session: ePoster Display
1340P - The characteristics of the intestinal flora of advanced non-small cell lung cancer in China and its role in chemotherapy based on metagenomics
Presenter: Xiangjun Liu
Session: ePoster Display
Resources:
Abstract
1341P - NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
Presenter: Agathe Dehem
Session: ePoster Display
1342P - Genetic mutations in PIK3CA predict liver metastases in patients with lung adenocarcinoma
Presenter: Jun Zhao
Session: ePoster Display
1343P - Understanding patient and caregiver perceptions of quality of life (QoL) impacts in lung cancer through social listening
Presenter: Michele Montrone
Session: ePoster Display
1344P - Molecular features of young cannabis smokers with advanced non-small cell lung cancer (aNSCLC)
Presenter: Mihaela Aldea
Session: ePoster Display
1345P - Using social listening to understand stakeholder perceptions of the patient journey in lung cancer
Presenter: Ana Rodrigues
Session: ePoster Display
1346P - Diagnosed with non-small cell lung cancer but not treated
Presenter: Thomas Hofmarcher
Session: ePoster Display
1347P - Real-life patient management patterns in one of the largest Hungarian lung cancer centers
Presenter: Andrea Biró
Session: ePoster Display